Short seller alleges misleading investors

A short seller alleged Tuesday that the beauty and wellness company rare technology has been misleading investors and is not…

Wells Fargo turns bullish on this biotech company

Neurocrine Biosciences' drug portfolio is turning a corner, and the company will soon be “knocking on the doors of the…